Clinical Research Directory
Browse clinical research sites, groups, and studies.
Suzetrigine-enhanced MultimOdal Opioid-sparing THerapy in Cardiac and Bariatric SURGery
Sponsor: Icahn School of Medicine at Mount Sinai
Summary
This is prospective, randomized study. The purpose of this study is to evaluate whether the addition of Suzetrigine to well established multimodal pain regimen for participants undergoing bariatric patients undergoing weight-loss surgery and cardiac patients undergoing sternotomy will reduce post-operative opioid consumption and pain scores.
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
235
Start Date
2026-04
Completion Date
2026-12-22
Last Updated
2026-04-20
Healthy Volunteers
No
Interventions
Suzetrigine
Suzetrigine is a new pain medication that works by blocking a specific sodium channel (NAV 1.8) in the peripheral nerves and preventing pain signals from reaching the spinal cord and brain.
Placebo
Matching placebo
Locations (1)
Mount Sinai Morningside
New York, New York, United States